Nitrosamines Regulatory Requirements In The Pharmaceutical Industry: Gain The Full Picture In Regulatory Affairs, Sales, Quality, And Analytical Departments (ONLINE COURSE: Apr 20Th-21St, 2026)

(MENAFN- GlobeNewsWire - Nasdaq) Emerging market opportunities include strategies for addressing shifting nitrosamine regulations impacting 30% of new and existing products, including generics. This creates demand for expertise in regulatory alignment, risk assessments, and team growth, particularly benefitting SMEs and those new to the space.

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets's offering.
Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics.

Regulatory expectations have changed frequently and vary globally. In this webinar, we will discuss the major requirements and strategies. Those new to the subject and those growing their nitrosamine team will find value in seeing the entire picture. Experienced Small and Medium-sized Enterprises (SMEs) will receive detailed instructions for common pain points, like risk assessments.

Who Should Attend:

This course will benefit nitrosamine decision makers and those who can benefit from a broader understanding of the full picture of nitrosamines in regulatory affairs, sales, quality, and analytical departments.

Key Topics Covered:

Day 1

• History and background
• Classes of nitrosamines
• Regulatory update
• Team building
• Risk assessments
• At risk structures
• Limit determination

Day 2

• Nitrosation Assay Procedure (NAP) test
• Analytical instruments and methods
• Control strategy
• Remediation
• Post approval changes
• Where are we going? Future state and unanswered questions

CPD Hours: 6

Speakers

Jason Brown

Jason Brown brings a wealth of knowledge and practical experience to his role as Senior Analytical Sciences Manager at Adare Pharma Solutions, where he serves as the global nitrosamine subject matter expert.

He has led Adare's innovative approaches to understanding nitrosamine formation, measurement, and mitigation to ensure regulatory compliance internally and for our customers. Jason has led numerous dialogues on the subject of nitrosamines through panel discussions, webinars, posters, articles, and regular contributions to the USP Nitrosamine Forum. Jason has a BS in Chemistry from George Fox University.

For more information about this training visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14042026004107003653ID1110979228